Does skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT predict Bone Marrow Failure After 223Ra Therapy?
223Ra was beneficial and reduced the risk of death even in patients with a high skeletal tumor burden. Fluoride PET/CT is able to determine which patients will benefit from 223Ra and which will develop BMF.
The Nocturia Quality-of-Life questionnaire represents a useful tool to predict nocturia and risk of falling in Japanese patients.